These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20307577)

  • 21. Establishment of Vero cell lines persistently harboring a yellow fever virus 17D subgenomic replicon.
    Saito K; Shimasaki K; Fukasawa M; Suzuki R; Okemoto-Nakamura Y; Katoh K; Takasaki T; Hanada K
    Virus Res; 2022 Dec; 322():198935. PubMed ID: 36152929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying initiation and elongation inhibitors of dengue virus RNA polymerase in a high-throughput lead-finding campaign.
    Smith TM; Lim SP; Yue K; Busby SA; Arora R; Seh CC; Wright SK; Nutiu R; Niyomrattanakit P; Wan KF; Beer D; Shi PY; Benson TE
    J Biomol Screen; 2015 Jan; 20(1):153-63. PubMed ID: 25252731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biflavonoids of Dacrydium balansae with potent inhibitory activity on dengue 2 NS5 polymerase.
    Coulerie P; Eydoux C; Hnawia E; Stuhl L; Maciuk A; Lebouvier N; Canard B; Figadère B; Guillemot JC; Nour M
    Planta Med; 2012 May; 78(7):672-7. PubMed ID: 22411725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody Assays.
    Caì Y; Iwasaki M; Beitzel BF; Yú S; Postnikova EN; Cubitt B; DeWald LE; Radoshitzky SR; Bollinger L; Jahrling PB; Palacios GF; de la Torre JC; Kuhn JH
    Viruses; 2018 Nov; 10(11):. PubMed ID: 30463334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Dengue type-2 virus replicons expressing GFP reporter gene in study of viral RNA replication.
    Leardkamolkarn V; Sirigulpanit W; Chotiwan N; Kumkate S; Huang CY
    Virus Res; 2012 Feb; 163(2):552-62. PubMed ID: 22197424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-throughput screening using dengue virus reporter genomes.
    Fischl W; Bartenschlager R
    Methods Mol Biol; 2013; 1030():205-19. PubMed ID: 23821271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A reporter-based assay for identifying hepatitis C virus inhibitors based on subgenomic replicon cells.
    Lee JC; Chang CF; Chi YH; Hwang DR; Hsu JT
    J Virol Methods; 2004 Mar; 116(1):27-33. PubMed ID: 14715304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction of self-replicating subgenomic West Nile virus replicons for screening antiviral compounds.
    Alcaraz-Estrada SL; Reichert ED; Padmanabhan R
    Methods Mol Biol; 2013; 1030():283-99. PubMed ID: 23821276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-Throughput Screening Assays for Dengue Antiviral Drug Development.
    Jabanathan SG; Xuan LZ; Ramanathan B
    Methods Mol Biol; 2021; 2296():279-302. PubMed ID: 33977455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and purification of dengue virus NS5 polymerase and development of a high-throughput enzymatic assay for screening inhibitors of dengue polymerase.
    Gong EY; Kenens H; Ivens T; Dockx K; Vermeiren K; Vandercruyssen G; Devogelaere B; Lory P; Kraus G
    Methods Mol Biol; 2013; 1030():237-47. PubMed ID: 23821273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effective inhibition of Japanese encephalitis virus replication by small interfering RNAs targeting the NS5 gene.
    Qi WB; Hua RH; Yan LP; Tong GZ; Zhang GH; Ren T; Wu DL; Liao M
    Virus Res; 2008 Mar; 132(1-2):145-51. PubMed ID: 18190994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of a small molecule inhibitor targeting dengue virus NS5 RNA-dependent RNA polymerase.
    Shimizu H; Saito A; Mikuni J; Nakayama EE; Koyama H; Honma T; Shirouzu M; Sekine SI; Shioda T
    PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007894. PubMed ID: 31738758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incorporation of dengue virus replicon into virus-like particles by a cell line stably expressing precursor membrane and envelope proteins of dengue virus type 2.
    Lai CY; Hu HP; King CC; Wang WK
    J Biomed Sci; 2008 Jan; 15(1):15-27. PubMed ID: 17768670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Escape Mutations in NS4B Render Dengue Virus Insensitive to the Antiviral Activity of the Paracetamol Metabolite AM404.
    van Cleef KW; Overheul GJ; Thomassen MC; Marjakangas JM; van Rij RP
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2554-7. PubMed ID: 26856827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of robust in vitro RNA-dependent RNA polymerase assay as a possible platform for antiviral drug testing against dengue.
    Amraiz D; Zaidi NU; Fatima M
    Enzyme Microb Technol; 2016 Oct; 92():26-30. PubMed ID: 27542741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library.
    Hernandez-Morales I; Geluykens P; Clynhens M; Strijbos R; Goethals O; Megens S; Verheyen N; Last S; McGowan D; Coesemans E; De Boeck B; Stoops B; Devogelaere B; Pauwels F; Vandyck K; Berke JM; Raboisson P; Simmen K; Lory P; Van Loock M
    Antiviral Res; 2017 Nov; 147():149-158. PubMed ID: 29037976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computational screening of medicinal plant phytochemicals to discover potent pan-serotype inhibitors against dengue virus.
    Tahir Ul Qamar M; Maryam A; Muneer I; Xing F; Ashfaq UA; Khan FA; Anwar F; Geesi MH; Khalid RR; Rauf SA; Siddiqi AR
    Sci Rep; 2019 Feb; 9(1):1433. PubMed ID: 30723263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NS5 from Dengue Virus Serotype 2 Can Adopt a Conformation Analogous to That of Its Zika Virus and Japanese Encephalitis Virus Homologues.
    El Sahili A; Soh TS; Schiltz J; Gharbi-Ayachi A; Seh CC; Shi PY; Lim SP; Lescar J
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zika Virus Replicons for Drug Discovery.
    Xie X; Zou J; Shan C; Yang Y; Kum DB; Dallmeier K; Neyts J; Shi PY
    EBioMedicine; 2016 Oct; 12():156-160. PubMed ID: 27658737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a novel dicistronic reporter-selectable hepatitis C virus replicon suitable for high-throughput inhibitor screening.
    Hao W; Herlihy KJ; Zhang NJ; Fuhrman SA; Doan C; Patick AK; Duggal R
    Antimicrob Agents Chemother; 2007 Jan; 51(1):95-102. PubMed ID: 17060518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.